You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 70677-1105


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 70677-1105

Drug Name NDC Price/Unit ($) Unit Date
FT ANTI-DIARRHEAL-ANTIGAS CPLT 70677-1105-01 0.29397 EACH 2025-01-22
FT ANTI-DIARRHEAL-ANTIGAS CPLT 70677-1105-01 0.29517 EACH 2024-12-18
FT ANTI-DIARRHEAL-ANTIGAS CPLT 70677-1105-01 0.29871 EACH 2024-11-20
FT ANTI-DIARRHEAL-ANTIGAS CPLT 70677-1105-01 0.29286 EACH 2024-10-23
FT ANTI-DIARRHEAL-ANTIGAS CPLT 70677-1105-01 0.30002 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 70677-1105

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 70677-1015

Understanding the National Drug Code (NDC)

Before diving into the market analysis and price projections, it is crucial to understand what an NDC is and its components. The National Drug Code (NDC) is a unique 10-digit numerical identifier assigned to drugs in the United States. It consists of three segments: the labeler code, the product code, and the package code[5].

Labeler, Product, and Package Codes

  • Labeler Code: Assigned by the FDA, this identifies the firm that manufactures, repackages, or distributes the drug.
  • Product Code: Identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: Identifies the package size and type.

Current NDC Format and Proposed Changes

The current NDC format is a 10-digit number, often in the 5-4-2, 5-3-2, or 4-4-2 configurations. However, the FDA has proposed a rule to transition to a 12-digit NDC format to minimize confusion and medication errors. This change aims to standardize the length and format of NDCs, ensuring a smoother transition and reducing healthcare costs[2].

Market Analysis for NDC 70677-1015

Industry Context

The pharmaceutical market, particularly the biopharma and biotech sectors, is experiencing rapid growth driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029, while the biotech sector is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].

Generic Drug Impact

Generic drug approvals significantly impact the market by reducing drug prices and increasing savings for patients. For example, generic versions of drugs like lurasidone hydrochloride (brand: Latuda) have led to substantial savings, with the average price of a tablet dropping from $47.71 to $1.87, resulting in over $4.4 billion in savings[4].

Competition and Pricing

The pricing of drugs with the NDC 70677-1015 will be influenced by the level of competition in the market. If the drug has generic versions or faces competition from other similar products, the prices are likely to decrease. The entry of generic drugs into the market can lead to significant price reductions, as seen with other products where prices have dropped by up to 96% after generic approvals[4].

Price Projections

Current Pricing

To project future prices, it is essential to understand the current pricing structure. However, specific pricing details for NDC 70677-1015 are not provided in the available sources. Generally, prices are determined by factors such as production costs, market demand, and regulatory approvals.

Impact of Generic Approvals

If generic versions of the drug associated with NDC 70677-1015 are approved, the prices are likely to drop significantly. This is because generic drugs typically enter the market at a lower price point than their brand-name counterparts, leading to increased competition and lower prices for consumers.

Regulatory Changes

The proposed transition to a 12-digit NDC format may have indirect effects on pricing by reducing confusion and medication errors, which could lead to more efficient healthcare systems and potentially lower costs. However, this change is more about standardization and less about direct price impact[2].

Key Factors Influencing Price

  • Market Competition: The presence of generic or brand-name competitors can significantly reduce prices.
  • Regulatory Approvals: Changes in regulatory frameworks, such as the approval of generic versions, can impact pricing.
  • Technological Advancements: Innovations in drug development and manufacturing can affect production costs and, subsequently, market prices.
  • Patient Demand: The demand for the drug, influenced by factors like disease prevalence and treatment options, can impact pricing.

Illustrative Statistics

  • Generic drug approvals in 2022 led to $18.9 billion in total savings over 12 months, with some products seeing price reductions of up to 96%[4].
  • The biopharma market is projected to grow to over $400 billion by 2029, indicating a robust and expanding market[3].

Stakeholder Preparation

For stakeholders, including manufacturers, distributors, and healthcare providers, preparing for the transition to a 12-digit NDC format is crucial. This involves updating labeling, drug listing submissions, and ensuring that all systems are compatible with the new format to avoid disruptions during the transition period[2].

Conclusion

The market analysis and price projections for the drug associated with NDC 70677-1015 depend on several factors, including market competition, regulatory changes, and technological advancements. The potential for generic approvals and the transition to a new NDC format are key considerations that could significantly impact pricing and market dynamics.

Key Takeaways

  • NDC Format: The current 10-digit NDC format is proposed to be changed to a 12-digit format to standardize and reduce errors.
  • Generic Approvals: Generic drug approvals can lead to significant price reductions, as seen in other products.
  • Market Competition: The presence of competitors, especially generic versions, can drive down prices.
  • Regulatory Changes: Changes in regulatory frameworks can impact pricing and market efficiency.
  • Technological Advancements: Innovations in drug development can affect production costs and market prices.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique 10-digit numerical identifier assigned to drugs in the United States, consisting of labeler, product, and package codes.

How do generic drug approvals affect pricing?

Generic drug approvals can significantly reduce prices by introducing competition into the market, often leading to price drops of up to 90% or more.

What is the proposed change to the NDC format?

The FDA has proposed transitioning from the current 10-digit NDC format to a 12-digit format to standardize and reduce confusion and medication errors.

How does market competition influence drug pricing?

Market competition, especially from generic versions, can drive down prices by increasing the supply of the drug and reducing the market share of brand-name products.

What role do technological advancements play in drug pricing?

Technological advancements in drug development and manufacturing can affect production costs, which in turn can influence market prices by making drugs more affordable or reducing the cost of production.

Sources

  1. FDA.report: NDC 70677-1015 - FDA.report
  2. FDA: Future Format of the National Drug Code - FDA
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. FDA: Estimating Cost Savings from New Generic Drug Approvals in 2022
  5. AAPC: NDC Code Lookup - CPT/HCPCS Cross-Reference

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.